Guidance

Commission to the ACMD: scheduling under the Misuse of Drugs Regulations 2001

The Advisory Council on the Misuse of Drugs has been asked to consider the appropriate scheduling of cannabis-related products.

Documents

Commission to the ACMD: scheduling under the Misuse of Drugs Regulations 2001

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email alternativeformats@homeoffice.gsi.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Annex A – Listings contained in Schedule 1 to the 2001 MDA regulations associated with CMO’s definition of Cannabis based medicinal products.

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email alternativeformats@homeoffice.gsi.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Letter from the Home Secretary to Dr Owen Bowden-Jones

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email alternativeformats@homeoffice.gsi.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The Home Secretary has formally commissioned the Advisory Council on the Misuse of Drugs (ACMD) for their expert advice and recommendations on whether cannabis-related products should be rescheduled under the 2001 Regulations.

Published 3 July 2018